2018
|
Invention
|
Use of vdas to enhance immunomodulating therapies against tumors. Methods for producing an anti-t... |
2016
|
Invention
|
Compositions and methods for inhibition of cathepsins. This invention is directed to compound of ... |
|
Invention
|
Compositions and methods for inhibition of cathepsins.
This present disclosure is directed to co... |
|
Invention
|
Compositions and methods for inhibition of cathepsins. This present disclosure is directed to com... |
2014
|
Invention
|
Functionalized stilbene derivatives as improved vascular targeting agents. Novel stilbenoid compo... |
2011
|
Invention
|
Method for treating hematopoietic neoplasms. This invention relates to methods for treating a hem... |
2004
|
Invention
|
Chromene-containing compounds with anti-tubulin and vascular targeting activity. Chrome compounds... |
|
Invention
|
Compositions and methods with enhanced therapeutic activity. Novel quinone and catechol compositi... |
|
Invention
|
Catechol compositions and use thereof. Novel quinone and catechol compositions, compositions cont... |
2003
|
Invention
|
Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agen... |
|
Invention
|
Tubulin binding ligands and corresponding prodrug constructs. A diverse set of tubulin binding ag... |
|
Invention
|
Tubulin binding agents and corresponding prodrug constructs. A diverse set of tubulin binding age... |
2002
|
Invention
|
Compositions and methods for use in targeting vascular destruction. Treatment of warm-blooded ani... |
2001
|
Invention
|
Use of combretastatin a4 and its prodrugs as an immune enhancing therapy. A method of treating im... |
|
Invention
|
Methods for modulating tumor growth and metastasis. Methods and pharmaceutical compositions for m... |
|
Invention
|
Efficient method of synthesizing combretastatin a-4 prodrugs. Methods of synthesizing a phosphate... |
|
Invention
|
Tubulin binding ligands and corresponding prodrug constructs. A diverse set of tubulin binding li... |